Citations (65)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Yifang Li, Yanzhen Chen, Xing Tian, Shanshan Zhang & Jian Jiao. (2021) Comparison of Clinical Characteristics Between Obese and Non-Obese Patients with Nonalcoholic Fatty Liver Disease (NAFLD). Diabetes, Metabolic Syndrome and Obesity 14, pages 2029-2039.
Read now
Read now
Cene Skubic, Živa Drakulić & Damjana Rozman. (2018) Personalized therapy when tackling nonalcoholic fatty liver disease: a focus on sex, genes, and drugs. Expert Opinion on Drug Metabolism & Toxicology 14:8, pages 831-841.
Read now
Read now
Fabio Nascimbeni, Stefano Ballestri, Mariana Verdelho Machado, Alessandro Mantovani, Helena Cortez-Pinto, Giovanni Targher & Amedeo Lonardo. (2018) Clinical relevance of liver histopathology and different histological classifications of NASH in adults. Expert Review of Gastroenterology & Hepatology 12:4, pages 351-367.
Read now
Read now
Articles from other publishers (62)
Arka De, Manu Mehta, Priya Singh, Naveen Bhagat, Suvradeep Mitra, Ashim Das & Ajay Duseja. (2023) Lean Indian patients with non-alcoholic fatty liver disease (NAFLD) have less metabolic risk factors but similar liver disease severity as non-lean patients with NAFLD. International Journal of Obesity 47:10, pages 986-992.
Crossref
Crossref
Ansel Tang, Cheng Han Ng, Poh Hui Phang, Kai En Chan, Yip Han Chin, Clarissa Elysia Fu, Rebecca Wenling Zeng, Jieling Xiao, Darren Jun Hao Tan, Jingxuan Quek, Wen Hui Lim, Lung Yi Mak, Jiong-wei Wang, Nicholas W.S. Chew, Nicholas Syn, Daniel Q. Huang, Mohammad Shadab Siddiqui, Arun Sanyal, Mark Muthiah & Mazen Noureddin. (2023) Comparative Burden of Metabolic Dysfunction in Lean NAFLD vs Non-lean NAFLD - A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 21:7, pages 1750-1760.e12.
Crossref
Crossref
Francesco Maria Calabrese, Giuseppe Celano, Caterina Bonfiglio, Angelo Campanella, Isabella Franco, Alessandro Annunziato, Gianluigi Giannelli, Alberto Ruben Osella & Maria De Angelis. (2023) Synergistic Effect of Diet and Physical Activity on a NAFLD Cohort: Metabolomics Profile and Clinical Variable Evaluation. Nutrients 15:11, pages 2457.
Crossref
Crossref
Yusuf Yilmaz. (2023)
Editorial: “being normal weight each day keeps
NAFLD
and fibrosis away”—the importance of reducing cumulative exposure to overweight
. Alimentary Pharmacology & Therapeutics 57:10, pages 1166-1167.
Crossref
Crossref
Ajay Duseja, Arka De & Vincent Wong. (2023) Special Population. Clinics in Liver Disease 27:2, pages 451-469.
Crossref
Crossref
C.E. Builes-Montaño, E. Pérez-Giraldo, S. Castro-Sánchez, N.A. Rojas-Henao, O.M. Santos-Sánchez & J.C. Restrepo-Gutiérrez. (2023) Metabolic disorders across the body mass index spectrum in a Colombian population with nonalcoholic fatty liver disease. Revista de Gastroenterología de México (English Edition).
Crossref
Crossref
C.E. Builes-Montaño, E. Pérez-Giraldo, S. Castro-Sánchez, N.A. Rojas-Henao, O.M. Santos-Sánchez & J.C. Restrepo-Gutiérrez. (2023) Trastornos metabólicos en el espectro completo del índice de masa corporal en una población colombiana con enfermedad de hígado graso no alcohólico. Revista de Gastroenterología de México.
Crossref
Crossref
Jian Wang, Jiacheng Liu, Yilin Liu, Ruifei Xue, Jie Zhan, Suling Jiang, Li Wang, Xiaomin Yan, Yali Xiong, Juan Xia, Shengxia Yin, Xin Tong, Yuxin Chen, Jie Li, Rui Huang & Chao Wu. (2022) Clinical features of chronic hepatitis B patients with lean nonalcoholic fatty liver disease. Hepatology Research 53:3, pages 184-195.
Crossref
Crossref
Johanna K. DiStefano & Glenn S. Gerhard. (2022) NAFLD in normal weight individuals. Diabetology & Metabolic Syndrome 14:1.
Crossref
Crossref
Lu Liu, Xiaolan Shi, Jingwen Gao, Chunfang Xu & Xiaolin Liu. (2022) Predictive Risk Factors of Nonalcoholic Fatty Liver Disease in a Lean Chinese Population. Journal of Personalized Medicine 12:12, pages 1958.
Crossref
Crossref
Anwesha Gangopadhyay, Radwa Ibrahim, Karli Theberge, Meghan May & Karen L. Houseknecht. (2022) Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines. Frontiers in Neuroscience 16.
Crossref
Crossref
Fakhar Ali Qazi-Arisar, Raj Uchila, Catherine Chen, Cathy Yang, Shi-Yi Chen, Ravikiran Sindhuvalada Karnam, Amirhossein Azhie, Wei Xu, Zita Galvin, Nazia Selzner, Leslie Lilly & Mamatha Bhat. (2022)
Divergent trajectories of lean
vs
obese non-alcoholic steatohepatitis patients from listing to post-transplant: A retrospective cohort study
. World Journal of Gastroenterology 28:26, pages 3218-3231.
Crossref
Crossref
Wenting Wang, Jianping Ren, Wenzhao Zhou, Jinyu Huang, Guomin Wu, Fenfang Yang, Shuang Yuan, Juan Fang, Jing Liu, Yao Jin, Haiyang Qi, Yuyang Miao, Yanna Le, Cenhong Ge, Xiantao Qiu, JinJing Wang, Ping Huang, Zixin Liu & Sheng Wang. (2022) Lean non-alcoholic fatty liver disease (Lean-NAFLD) and the development of metabolic syndrome: a retrospective study. Scientific Reports 12:1.
Crossref
Crossref
Eda Kaya & Yusuf Yilmaz. (2021) Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver. Journal of Clinical and Translational Hepatology 10:2, pages 329-338.
Crossref
Crossref
Daljeet Chahal, Divya Sharma, Sareh Keshavarzi, Fakhar Ali Qazi Arisar, Keyur Patel, Wei Xu & Mamatha Bhat. (2022) Distinctive clinical and genetic features of lean vs overweight fatty liver disease using the UK Biobank. Hepatology International 16:2, pages 325-336.
Crossref
Crossref
Anca Trifan, Adrian Rotaru, Remus Stafie, Ermina Stratina, Sebastian Zenovia, Robert Nastasa, Laura Huiban, Tudor Cuciureanu, Cristina Muzîca, Stefan Chiriac, Irina Gîrleanu, Ana-Maria Sîngeap, Catalin Sfarti, Camelia Cojocariu & Carol Stanciu. (2022) Clinical and Laboratory Characteristics of Normal Weight and Obese Individuals with Non-Alcoholic Fatty Liver Disease. Diagnostics 12:4, pages 801.
Crossref
Crossref
饺饺 黄. (2022) Related Factors of Metabolic Associated Fatty Liver Disease. Advances in Clinical Medicine 12:01, pages 331-336.
Crossref
Crossref
Eunice Xiang-Xuan Tan, Jonathan Wei-Jie Lee, Nur Halisah Jumat, Wah-Kheong Chan, Sombat Treeprasertsuk, George Boon-Bee Goh, Jian-Gao Fan, Myeong Jun Song, Phunchai Charatcharoenwitthaya, Ajay Duseja, Kento Imajo, Atsushi Nakajima, Yosuke Seki, Kazunori Kasama, Satoru Kakizaki, Laurentius A. Lesmana, Kenneth I. Zheng, Ming-Hua Zheng, Calvin J. Koh, Khek-Yu Ho, Khean-Lee Goh, Vincent Wai-Sun Wong & Yock-Young Dan. (2022) Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study. Metabolism 126, pages 154911.
Crossref
Crossref
Elke Roeb. 2022. Nicht-alkoholische Fettlebererkrankung. Nicht-alkoholische Fettlebererkrankung
167
179
.
Qinqiu Wang, Xiaoying Shi, Jinghua Wang, Juanwen Zhang & Chengfu Xu. (2021) Low serum vitamin D concentrations are associated with obese but not lean NAFLD: a cross-sectional study. Nutrition Journal 20:1.
Crossref
Crossref
Hadi Emamat, Hamid Ghalandari, Ali Saneei Totmaj, Hadith Tangestani & Azita Hekmatdoost. (2021) Calcium to magnesium intake ratio and non-alcoholic fatty liver disease development: a case-control study. BMC Endocrine Disorders 21:1.
Crossref
Crossref
Chia-Wen Lu, Yi-Chen Lee, Chien-Hsieh Chiang, Hao-Hsiang Chang, Wei-Shiung Yang & Kuo-Chin Huang. (2021) Independent Dose–Response Associations between Fetuin-A and Lean Nonalcoholic Fatty Liver Disease. Nutrients 13:9, pages 2928.
Crossref
Crossref
Mitra Ahadi, Kasra Molooghi, Negin Masoudifar, Ali Beheshti Namdar, Hassan Vossoughinia & Mohammadreza Farzanehfar. (2020) A review of non‐alcoholic fatty liver disease in non‐obese and lean individuals. Journal of Gastroenterology and Hepatology 36:6, pages 1497-1507.
Crossref
Crossref
Sheila Maier, Amanda Wieland, Melanie Cree-Green, Kristen Nadeau, Shelby Sullivan, Miguel A. Lanaspa, Richard J. Johnson & Thomas Jensen. (2021) Lean NAFLD: an underrecognized and challenging disorder in medicine. Reviews in Endocrine and Metabolic Disorders 22:2, pages 351-366.
Crossref
Crossref
Stavroula Kanoni, Satish Kumar, Charalampia Amerikanou, Mary Jo Kurth, Maria G. Stathopoulou, Stephane Bourgeois, Christine Masson, Aimo Kannt, Lucia Cesarini, Maria-Spyridoula Kontoe, Maja Milanović, Francisco J. Roig, Mirjana Beribaka, Jonica Campolo, Nuria Jiménez-Hernández, Nataša Milošević, Carlos Llorens, Ilias Smyrnioudis, M. Pilar Francino, Nataša Milić, Andriana C. Kaliora, Maria Giovanna Trivella, Mark W. Ruddock, Milica Medić-Stojanoska, Amalia Gastaldelli, John Lamont, Panos Deloukas, George V. Dedoussis & Sophie Visvikis-Siest. (2021) Nutrigenetic Interactions Might Modulate the Antioxidant and Anti-Inflammatory Status in Mastiha-Supplemented Patients With NAFLD. Frontiers in Immunology 12.
Crossref
Crossref
Ethan M. Weinberg, Huy N. Trinh, Roberto J. Firpi, Kalyan Ram Bhamidimarri, Samuel Klein, Jonathan Durlam, Stephanie Watkins, K. Rajender Reddy, Michael Weiss, Richard C. Zink & Anna S. Lok. (2021) Lean Americans With Nonalcoholic Fatty Liver Disease Have Lower Rates of Cirrhosis and Comorbid Diseases. Clinical Gastroenterology and Hepatology 19:5, pages 996-1008.e6.
Crossref
Crossref
Anders Batman Mjelle, Anesa Mulabecirovic, Edda Jonina Olafsdottir, Odd Helge Gilja, Roald Flesland Havre & Mette Vesterhus. (2021) Controlled Attenuation Parameter in Healthy Individuals Aged
8–70 Years. Ultrasound International Open 07:01, pages E6-E13.
Crossref
Crossref
Yu-Ming Cheng, Jia-Horng Kao & Chia-Chi Wang. (2021) The metabolic profiles and body composition of lean metabolic associated fatty liver disease. Hepatology International 15:2, pages 405-412.
Crossref
Crossref
Ahyoung Kim, Arunkumar Krishnan, James P. Hamilton & Tinsay A. Woreta. (2021) The Impact of Dietary Patterns and Nutrition in Nonalcoholic Fatty Liver Disease. Gastroenterology Clinics of North America 50:1, pages 217-241.
Crossref
Crossref
Ines Bilic-Curcic, Maja Cigrovski Berkovic, Lucija Virovic-Jukic & Anna Mrzljak. (2021) Shifting perspectives – interplay between non-alcoholic fatty liver disease and insulin resistance in lean individuals. World Journal of Hepatology 13:1, pages 80-93.
Crossref
Crossref
Evangelia Makri, Antonis Goulas & Stergios A. Polyzos. (2021) Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease. Archives of Medical Research 52:1, pages 25-37.
Crossref
Crossref
Lampros Chrysavgis, Eleftheria Ztriva, Adonis Protopapas, Konstantinos Tziomalos & Evangelos Cholongitas. (2020) Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management. World Journal of Gastroenterology 26:42, pages 6514-6528.
Crossref
Crossref
Pinar Hamurcu Varol, Eda Kaya, Emel Alphan & Yusuf Yilmaz. (2019) Role of intensive dietary and lifestyle interventions in the treatment of lean nonalcoholic fatty liver disease patients. European Journal of Gastroenterology & Hepatology 32:10, pages 1352-1357.
Crossref
Crossref
Maki Tobari & Etsuko Hashimoto. (2020) Characteristic Features of Nonalcoholic Fatty Liver Disease in Japan with a Focus on the Roles of Age, Sex and Body Mass Index. Gut and Liver 14:5, pages 537-545.
Crossref
Crossref
Ahad Eshraghian, Saman Nikeghbalian, Bita Geramizadeh, Kourosh Kazemi, Alireza Shamsaeefar & Seyed Ali Malek-Hosseini. (2020) Characterization of biopsy proven non-alcoholic fatty liver disease in healthy non-obese and lean population of living liver donors: The impact of uric acid. Clinics and Research in Hepatology and Gastroenterology 44:4, pages 572-578.
Crossref
Crossref
Shah Mohammad Fahim, Muhammad Abdul Baker Chowdhury & Shahinul Alam. (2020) Non-alcoholic fatty liver disease (NAFLD) among underweight adults. Clinical Nutrition ESPEN 38, pages 80-85.
Crossref
Crossref
Qing Ye, Biyao Zou, Yee Hui Yeo, Jie Li, Daniel Q Huang, Yuankai Wu, Hongli Yang, Chuanli Liu, Leslie Y Kam, Xiang Xuan Eunice Tan, Nicholas Chien, Sam Trinh, Linda Henry, Christopher Donald Stave, Tetsuya Hosaka, Ramsey C Cheung & Mindie H Nguyen. (2020) Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology 5:8, pages 739-752.
Crossref
Crossref
Steven Young, Raseen Tariq, John Provenza, Sanjaya K. Satapathy, Kamal Faisal, Abhijit Choudhry, Scott L. Friedman & Ashwani K. Singal. (2020) Prevalence and Profile of Nonalcoholic Fatty Liver Disease in Lean Adults: Systematic Review and Meta‐Analysis. Hepatology Communications 4:7, pages 953-972.
Crossref
Crossref
Feruze Yilmaz Enc, Celal Ulasoglu, Alev Bakir & Yusuf Yilmaz. (2020) The interaction between current smoking and hemoglobin on the risk of advanced fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 32:5, pages 597-600.
Crossref
Crossref
Hongbin Li, Meihao Guo, Zhen An, Jun Meng, Jing Jiang, Jie Song & Weidong Wu. (2020) Prevalence and Risk Factors of Metabolic Associated Fatty Liver Disease in Xinxiang, China. International Journal of Environmental Research and Public Health 17:6, pages 1818.
Crossref
Crossref
Mathew Vadukoot Lazar, Malini Eapen, Harikumar R. Nair, Ismail Siyad & Rajesh Gopalakrishna. (2020) Correlation between insulin resistance and liver histology in patients with nonalcoholic steatohepatitis with and without obesity. Indian Journal of Gastroenterology 39:1, pages 42-49.
Crossref
Crossref
Qinpei Ding, Yubo Zhou, Shu Zhang & Min Liang. (2020) Association between hemoglobin levels and non-alcoholic fatty liver disease in patients with young-onset type 2 diabetes mellitus. Endocrine Journal 67:11, pages 1139-1146.
Crossref
Crossref
Eda Kaya & Yusuf Yilmaz. 2020. Obesity and Diabetes. Obesity and Diabetes
321
333
.
Qianyi Wang, Hong You, Xiaojuan Ou, Xinyan Zhao, Yameng Sun, Min Wang, Ping Wang, Yu Wang, Weijia Duan, Xiaoming Wang, Shanshan Wu, Yuanyuan Kong, Romil Saxena, Annette S. H. Gouw & Jidong Jia. (2019) Non-obese histologically confirmed NASH patients with abnormal liver biochemistry have more advanced fibrosis. Hepatology International 13:6, pages 766-776.
Crossref
Crossref
Somaya Albhaisi, Abhijit Chowdhury & Arun J. Sanyal. (2019) Non-alcoholic fatty liver disease in lean individuals. JHEP Reports 1:4, pages 329-341.
Crossref
Crossref
Stefania Di Mauro, Alessandra Scamporrino, Salvatore Petta, Francesca Urbano, Agnese Filippello, Marco Ragusa, Maria T. Di Martino, Francesca Scionti, Stefania Grimaudo, Rosaria M. Pipitone, Graziella Privitera, Antonino Di Pino, Roberto Scicali, Luca Valenti, Paola Dongiovanni, Anna Fracanzani, Agata M. Rabuazzo, Antonio Craxì, Michele Purrello, Francesco Purrello & Salvatore Piro. (2019) Serum coding and non‐coding RNAs as biomarkers of NAFLD and fibrosis severity. Liver International 39:9, pages 1742-1754.
Crossref
Crossref
Maki Tobari, Estuko Hashimoto, Makiko Taniai, Yuuichi Ikarashi, Kazuhisa Kodama, Tomomi Kogiso, Katsutoshi Tokushige, Nishino Takayoshi & Naotake Hashimoto. (2019) Characteristics of non-alcoholic steatohepatitis among lean patients in Japan: Not uncommon and not always benign. Journal of Gastroenterology and Hepatology 34:8, pages 1404-1410.
Crossref
Crossref
Alice Yuxin Wang, Jasbir Dhaliwal & Marialena Mouzaki. (2019) Lean non-alcoholic fatty liver disease. Clinical Nutrition 38:3, pages 975-981.
Crossref
Crossref
Lukas Denkmayr, Alexandra Feldman, Lars Stechemesser, Sebastian Eder, Stephan Zandanell, Michael Schranz, Michael Strasser, Ursula Huber-Schönauer, Stephan Buch, Jochen Hampe, Bernhard Paulweber, Carolin Lackner, Heike Haufe, Karl Sotlar, Christian Datz & Elmar Aigner. (2018) Lean Patients with Non-Alcoholic Fatty Liver Disease Have a Severe Histological Phenotype Similar to Obese Patients. Journal of Clinical Medicine 7:12, pages 562.
Crossref
Crossref
Philipp Bernhardt, Wolfgang Kratzer, Julian Schmidberger, Tilmann Graeter & Beate Gruener. (2018) Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosis. BMC Research Notes 11:1.
Crossref
Crossref
Giovanni Tarantino, Luigi Barrea, Domenico Capone, Vincenzo Citro, Teresa Mosca & Silvia Savastano. (2018) Hematocrit Values Predict Carotid Intimal-Media Thickness in Obese Patients With Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study. Frontiers in Endocrinology 9.
Crossref
Crossref
S. Sookoian & C. J. Pirola. (2018) Systematic review with meta-analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics 47:1, pages 16-25.
Crossref
Crossref
Christopher J. Schmoyer & Mohammad S. Siddiqui. (2017) Non-alcoholic Fatty Liver Disease in Non-obese Patients. Current Hepatology Reports 16:4, pages 382-390.
Crossref
Crossref
Anna Ludovica Fracanzani, Salvatore Petta, Rosa Lombardi, Giuseppina Pisano, Maurizio Russello, Dario Consonni, Vito Di Marco, Calogero Cammà, Laura Mensi, Paola Dongiovanni, Luca Valenti, Antonio Craxì & Silvia Fargion. (2017) Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity. Clinical Gastroenterology and Hepatology 15:10, pages 1604-1611.e1.
Crossref
Crossref
Ramesh Kumar & Shantam Mohan. (2017) Non-alcoholic Fatty Liver Disease in Lean Subjects: Characteristics and Implications. Journal of Clinical and Translational Hepatology XX:XX, pages 1-8.
Crossref
Crossref
S. Sookoian & C. J. Pirola. (2017) Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients. Alimentary Pharmacology & Therapeutics 46:2, pages 85-95.
Crossref
Crossref
Goh Eun Chung, Jeong Yoon Yim, Donghee Kim, Min-Sun Kwak, Jong In Yang, Su Jin Chung, Sun Young Yang & Joo Sung Kim. (2017) Associations between hemoglobin concentrations and the development of incidental metabolic syndrome or nonalcoholic fatty liver disease. Digestive and Liver Disease 49:1, pages 57-62.
Crossref
Crossref
Natalia Nuño-Lámbarri, Varenka J Barbero-Becerra, Misael Uribe & Norberto C Chávez-Tapia. (2017) Elevated cholesterol levels have a poor prognosis in a cholestasis scenario. Journal of Biochemical and Molecular Toxicology 31:1, pages e21831.
Crossref
Crossref
Kenneth Cusi. (2016) Nonalcoholic steatohepatitis in nonobese patients: Not so different after all. Hepatology 65:1, pages 4-7.
Crossref
Crossref
Jonathan Chung‐Fai Leung, Thomson Chi‐Wang Loong, Jeremy Lok Wei, Grace Lai‐Hung Wong, Anthony Wing‐Hung Chan, Paul Cheung‐Lung Choi, Sally She‐Ting Shu, Angel Mei‐Ling Chim, Henry Lik‐Yuen Chan & Vincent Wai‐Sun Wong. (2016) Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients. Hepatology 65:1, pages 54-64.
Crossref
Crossref
Natalia Nuño-Lámbarri, Varenka Barbero-Becerra, Misael Uribe & Norberto Chávez-Tapia. (2016) Mitochondrial Molecular Pathophysiology of Nonalcoholic Fatty Liver Disease: A Proteomics Approach. International Journal of Molecular Sciences 17:3, pages 281.
Crossref
Crossref
David Højland Ipsen, Pernille Tveden-Nyborg & Jens Lykkesfeldt. (2016) Normal weight dyslipidemia: Is it all about the liver?. Obesity 24:3, pages 556-567.
Crossref
Crossref